In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  sulindac
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2009-00880, UCI 97-05, R01CA088078, UCIRVINE-UCI-2002-2261, NCT00118365

2.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: CPMC-IRB-1095-072, NCI-P97-0110

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069390, P30CA006927, FCCC-01031, FCCC-63723, NCI-G02-2080, NCT00039520

4.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 80
Sponsor:
Protocol IDs: UUMC-9102, NCI-P92-0018

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and under at original diagnosis
Sponsor: NCI, Other
Protocol IDs: ARST0321, NCI-2009-00424, CDR0000322260, COG-ARST0321, U10CA098543, NCT00068419

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00837, CDR0000467755, MAY03-1-03, N01CN35000, P30CA015083, MAYO-030103, MAYO-1395-05, NCT00335504

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Tissue collection/Repository
Status: Completed
Age: 40 to 79
Sponsor: NCI
Protocol IDs: NCI-2009-00836, CDR0000496457, MAY03-1-02, MAYO-03-1-02, P30CA015083, N01CN35000, NCT00368927

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-111, NCT00392665

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000613992, ICORG-06-03, EUDRACT-2006-006051-12, EU-20876, ICORG 06-03 Epi Sulindac, NCT00755976

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: NCI-2009-01115, UARIZ-08-0841-04, CDR0000633938, N01CN35158, 08-0841-04, UAZ05-2-10, P30CA023074, UARIZ-UAZ05-2-10, NCT00841204

11.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000067922, 1997-96, NCI-P00-0150, UCIRVINE-97-05, NCT00005882

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 69
Sponsor: NCI, Other
Protocol IDs: 00039278, P01CA073992, NCT01187901

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: UARIZ-UAZ04-2-02, UARIZ-HSC-0553, UAZ04-2-02, NCT00245024

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: CDR0000447144, P30CA023074, UARIZ-UAZ04-2-02, UARIZ-HSC-0553, UAZ04-2-02, NCT00245024

15.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and older
Sponsor: NCI
Protocol IDs: NCCTG-909251, MAYO-909251, NCI-P91-0011

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000473167, MAYO-03-1-BIO, MAYO-CPN0576, MAYO-05-004233, MAY03-1-BIO, NCT00343629

17.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: 04-099, NCT00299195
New Search